Crohns Disease Treatment Market Size

Crohn’s Disease Treatment Market Size

Crohn’s Disease Treatment Market size was valued at USD 13.3 billion in 2023 growing at a CAGR of 4% from 2024 to 2032. One of the primary drivers for the growth is the increasing prevalence of Chron’s disease.

To get key market trends

  Download Free Sample

For instance, as per the report published by Crohn’s & Colitis Foundation of America it has been reported that approximately 1.6 million Americans currently have Crohn’s disease or ulcerative colitis. As many as 70,000 new cases of inflammatory bowel diseases (IBD) are diagnosed in the U.S. each year. Therefore, the advancement in diagnostic technologies enable earlier and more accurate detection of Crohn's disease. Thus, the rapid increase in the prevalence of Crohn’s disease globally is the major factor that is expanding the demand for effective treatment option, thereby driving the market growth. Further, the increasing awareness and improved diagnostic techniques have led to a higher diagnosis rate which enable for increasing number of patients seeking treatment, thereby contributing to the market growth.
 

Crohn's disease is a chronic inflammatory condition of the gastrointestinal tract. Treatment for Crohn’s disease can include the use of medication, alterations in diet and nutrition, and surgical procedures to repair or remove affected portions of the GI tract. Medication treating Crohn’s disease is designed to suppress the immune system’s abnormal inflammatory response that is causing the symptoms.